COVID-19/Coronavirus

Those with four or more ACEs by the fall of 2020 had 2.71-fold increased likelihood of reporting a new ACE in spring of 2021. Adverse childhood experience (ACE) exposure was common before and during the pandemic, and new ACEs were more likely among those who had multiple ACEs before or early in the pandemic, according...

A study of three patients with multiple sclerosis undergoing autologous hematopoietic stem cell transplantation found that high-dose cyclophosphamide may have modulated the inflammatory response to SARS-CoV-2 infection, preventing the development of COVID-19 and worsening of multiple sclerosis symptoms. Multiple sclerosis and SARS-CoV-2 infection share strong immune and inflammatory components. High-dose cyclophosphamide might reduce the inflammatory...

COVID-19 vaccination has been recommended as a priority for patients with NMOSD due to their high-risk status. This study investigates the safety profile of these vaccines for patients with NMOSD and other CNS demyelinating disorders, who were not included in previous trials. Although vaccination against COVID-19 is recommended for patients with neuromyelitis optica spectrum disorder...

Adults reporting post-COVID-19 condition say they have trouble getting, paying for care.   U.S. adults with post-COVID-19 condition (PCC) are more likely than other adults to have difficulty getting and paying for health care, according to a study published online April 10 in JAMA Network Open. Michael Karpman, from the Urban Institute in Washington, D.C.,...

Higher rates of vaccination seen in older patients; lower rates seen for metastatic solid tumors, with comorbidities For patients with cancer, age, cancer type, and comorbidity are associated with differential COVID-19 vaccine uptake rates, according to a study published online March 15 in Cancer. Dax Kurbegov, M.D., from the Sarah Cannon Research Institute in Nashville, Tennessee,...

Childhood asthma exacerbations were reduced during the early months of the COVID-19 pandemic. Continuing telehealth services as children resume typical activities will be vital to managing asthma. Asthma is the most common respiratory condition in children. Acute asthma exacerbations were reduced in the first year of the COVID-19 pandemic. Reduced asthma exacerbations may be explained...

The effects of COVID-19 vaccination on people with multiple sclerosis has not been studied in sufficient detail. This study provides an analysis of the available data. COVID-19 infection as well as the various COVID-19 vaccines have caused health complications for some patients with certain medical conditions. Despite the vaccine being available for a number of...

Rarely, some individuals may develop symptoms of alopecia areata following COVID-19 infection or vaccination, which are associated with pro-inflammatory cytokines that are also implicated in the pathogenesis of alopecia areata. Alopecia areata (AA) concerns have emerged following COVID-19 vaccination and infection. This cross-sectional analysis evaluated the relationship between COVID-19 infection or vaccination and AA. The...

Test will be sold without a prescription and can be used by anyone 14 years and older or by an adult or children ages 2 years and older A new at-home test will help people struggling with upper respiratory symptoms figure out whether they have COVID-19 or the flu. The U.S. Food and Drug Administration...